Contraception for adolescents
Keywords:contraception for adolescents, contraception for young women, long acting reversible contraception, unintended pregnancies
Adolescent pregnancy remains a significant issue in Thailand. The barrier to accessing reproductive health services is one of the obstacles to this problem. To mitigate these barriers, the Bureau of Reproductive Health, Department of Health, Ministry of Public Health provides Thai teens with friendly health services such as line official ‘TEEN CLUB’ and hotline ‘1663’. Additionally, the age restriction for long-acting reversible contraception (LARC) and financial barriers to access highly effective contraception have been removed. Healthcare providers’ knowledge, attitude, and correct understanding of contraception are essential contributors to teens’ reproductive health care. Current evidence supports the safety of contraceptive use among teens. As LARC is safe and highly effective in preventing unintended pregnancies, it should be considered a first option to use in combination with male condoms to protect both pregnancy and sexually transmitted diseases
2. World Bank Group. Fertility rate, total (births per woman) - Thailand [Internet]. 2018 [cited 2020 Sep 18]. Available from: https://data.worldbank.org/indicator/SP.DYN.TFRT.IN?locations=TH
3. Department of Health, the Bureau of Reproductive Health. The situation of reproductive health in adolescents and youth 2019 [Internet] 2019. [1 Sep 2020]. Accessed from: https://rh.anamai.moph.go.th/web-upload/migrated/files/rh/n86_0559234e9637e6dbb75f01b6e1e1a1aa_สถานการณ์RH_2562_Website.pdf (in Thai)
4. Martin JA, Hamilton BE, Osterman MJK, Driscoll AK. Births: final data for 2018. Natl Vital Stat Rep. 2019;68:1-47.
5. United Nations Population Fund. World Population Dashboard: Adolescent birth rate per 1,000 girls aged 15-19, 2020 [Internet]. 2020 [cited 2021 Feb 01]. Available from: https://www.unfpa.org/data/world-population-dashboard
6. Ganchimeg T, Ota E, Morisaki N, Laopaiboon M, Lumbiganon P, Zhang J, et al. Pregnancy and childbirth outcomes among adolescent mothers: a World Health Organization multicountry study. BJOG. 2014;121:40-8.
7. Traisrisilp K, Jaiprom J, Luewan S, Tongsong T. Pregnancy outcomes among mothers aged 15 years or less. J Obstet Gynaecol Res. 2015;41: 1726-31.
8. Finer LB, Zolna MR. Declines in Unintended Pregnancy in the United States, 2008-2011. N Engl J Med. 2016;374:843-52.
9. Udo IE, Lewis JB, Tobin JN, Ickovics JR. Intimate Partner Victimization and Health Risk Behaviors Among Pregnant Adolescents. Am J Public Health. 2016;106:1457-9.
10. Moffitt TE; E-Risk Study Team. Teen-aged mothers in contemporary Britain. J Child Psychol Psychiatry. 2002;43:727-42.
11. Assini-Meytin LC, Green KM. Long-term consequences of adolescent parenthood among African-American urban youth: a propensity score matching approach. J Adolesc Health. 2015;56:529-35.
12. Pilasan S. Adolescent pregnancy outcomes. Policy Brief [Internet]. 2014. [cited 2020 Sep 1]. Available from: https://www.hitap.net/wp-content/uploads/2014/10/effects on adolescent pregnancy-final-for-web.pdf. (in Thai)
13. WHO Regional Office for Europe and BZgA. Standards for sexuality education in Europe [Internet]. 2010 [cited 2020 Sep 20]. Available from: https://www.bzga-whocc.de/fileadmin/user_upload/WHO_BZgA_Standards_English.pdf
14. Birgisson NE, Zhao Q, Secura GM, Madden T, Peipert JF. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review. J Womens Health (Larchmt). 2015;24:349-53.
15. The American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices. Obstet Gynecol. 2018;131:e130-e9.
16. The American College of Obstetricians and Gynecologists. Committee Opinion No. 699: Adolescent Pregnancy, Contraception, and Sexual Activity. Obstet Gynecol. 2017;129:e142-e9.
17. Chacko MR. Contraception: Issues specific to adolescents. In: Blake D, Torchia MM, editors. UpToDate [Internet]. Waltham (MA): UpToDate; 2020 [updated 2020 Sep 14; [cited 2020 Sep 20]. Available from: https://www.uptodate.com/contents/contraception-issues-specific-to-adolescents
18. Department of Health, the Bureau of Reproductive Health. Adolescent Sexual and Reproductive Health and Rights [Internet]. 2016 [cited 2021 May 18]. Available from: https://multimedia.anamai.moph.go.th/news/191163-01/ (in Thai)
19. Chawachalasai P. Safe abortion: solution for adolescents with unintended pregnancies [Internet]. [cited 2020 Sep 1]. Available from: http://22.214.171.124/promote/sites/default/files/Helping Unprepared Pregnant Women.pdf (in Thai)
20. UNICEF Thailand. Situation Analysis of Adolescent Pregnancy in Thailand: 2015 Synthesis Report [Internet]. [cited 2020 Sep 1]. Available from: https://www.unicef.org/thailand/sites/unicef.org.thailand/files/2018-08/160705_SAAP_in_Thailand_report_TH.pdf. (in Thai)
21. Harper CC, Blum M, de Bocanegra HT, Darney PD, Speidel JJ, Policar M, et al. Challenges in translating evidence to practice: the provision of intrauterine contraception. Obstet Gynecol. 2008;111:1359-69.
22. Lersbuasin P, Santibenchakul S, Jaisamrarn U. Knowledge, attitude and practice regarding emergency contraceptive pills among health care providers. Thai Journal of Obstetrics and Gynaecology. 2015;23:34-43.
23. Boonsangsom P. TEEN CLUB: Unwanted Pregnancies Prevention [Internet]. 2020 [cited 2021 Apr 21]. Available from: https://www.thaihealth.or.th/Content/53150-launch. %20TEEN%20CLUB%20%20Prevent stomach problems, not ready.html (in Thai)
24. Panyapayatjati C. “AIDS-Unwanted Pregnancies” Hotline 1663 [Internet]. 2014. [cite 2021 Apr 21]. Available from: https://www.thaihealth.or.th/Content/25949-“AIDS-Pregnancy Unprepared”%20consult%201663%20.html (in Thai)
25. Hatcher RA, Trussell J, Nelson AL, Cates W, Jr, Kowal D, Policar MS. Contraceptive technology. 20th ed. New York: Ardent Media; 2011.
26. Nelson AL, Neinstein LS. Contraception. In: Neinstein LS, Gordon CM, Katzman DK, Rosen DS, Woods ER, editors. Handbook of Adolescent Health Care. Philadelphia: Lippincott Williams & Wilkins (LWW); 2009. p. 389-402.
27. The American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 710: counseling adolescents about contraception. Obstet Gynecol. 2017;130:e74-e80.
28. The American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 186: long-acting reversible contraception: Implants and Intrauterine devices. Obstet Gynecol. 2017; 130:e251-e69.
29. World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP), Knowledge for health project. Family Planning: A Global Handbook for Providers. 2018 edition. Baltimore and Geneva: CCP and WHO; 2018.
30. Santibenchakul S, Santipap M, Jaisamrarn U. Discontinuation of different contraceptive methods in Thai women. North American Forum on Family Planning; 10/7/2013; Contraception. 2013;88:450.
31. World Health Organization. Medical eligibility criteria for contraceptive use [Internet]. 5th ed. Geneva: WHO Press; 2015 [cited 2018 Feb 05]. Available from: http://apps.who.int/iris/bitstream/10665/181468/1/9789241549158_eng.pdf
32. Rinehart W, Rudy S, Drennan M. GATHER guide to counseling. Popul Rep J. 1998:1-31.
33. Hubacher D, Lopez L, Steiner MJ, Dorflinger L. Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons. Contraception. 2009;80:113-8.
34. Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016;65:1-104.
35. Trussell J. Contraceptive efficacy. In: Hatcher RA, Trussell J, Nelson AL, Cates W, Jr, Kowal D, Policar M, editors. Contraceptive technology. 20th ed. New York: Ardent Media; 2011. p. 779-88.
36. Diedrich JT, Klein DA, Peipert JF. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216:364.e1-12.
37. Tocce KM, Sheeder JL, Teal SB. Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference? Am J Obstet Gynecol. 2012;206:481.e1-7.
38. Buckingham P, Moulton JE, Subasinghe AK, Amos N, Mazza D. Acceptability of immediate postpartum and post-abortion long-acting reversible contraception provision to adolescents: a systematic review. Acta Obstet Gynecol Scand. 2021;100:629-40.
39. Department of Health, The Bureau of Reproductive Health. Reproductive health situation and policy [Internet]. 2020. [cited 2021 April 16]. Available from: http://apps.hpc.go.th/dl/web/upFile/2020/03-5005-20200304140549/f976bc499eec144cf12be50e3a3b74ba.pdf. (in Thai)
40. Bostick EA, Greenberg KB, Fagnano M, Baldwin CD, Halterman JS, Yussman SM. Adolescent Self-Reported Use of Highly Effective Contraception: Does Provider Counseling Matter? J Pediatr Adolesc Gynecol. 2020;33:529-35.
41. Caddy S, Yudin MH, Hakim J, Money DM. Best practices to minimize risk of infection with intrauterine device insertion. J Obstet Gynaecol Can. 2014;36:266-74.
42. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet. 2000;356:1013-9.
43. Stoddard AM, Xu H, Madden T, Allsworth JE, Peipert JF. Fertility after intrauterine device removal: a pilot study. Eur J Contracept Reprod Health Care. 2015;20:223-30.
44. Hov GG, Skjeldestad FE, Hilstad T. Use of IUD and subsequent fertility--follow-up after participation in a randomized clinical trial. Contraception. 2007;75:88-92.
45. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception. 1994;49:56-72.
46. Akers AY, Steinway C, Sonalkar S, Perriera LK, Schreiber C, Harding J, Garcia-Espana JF. Reducing pain during intrauterine device insertion: a randomized controlled trial in adolescents and young women. Obstetrics & Gynecology. 2017 Oct 1;130:795-802.
47. Matthews LR, O’Dwyer L, O’Neill E. Intrauterine device insertion failure after misoprostol administration: a systematic review. Obstet Gynecol. 2016;128:1084-91.
48. Aoun J, Dines VA, Stovall DW, Mete M, Nelson CB, Gomez-Lobo V. Effects of age, parity, and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol. 2014;123:585-92.
49. Keenahan L, Bercaw-Pratt JL, Adeyemi O, Hakim J, Sangi-Haghpeykar H, Dietrich JE. Rates of intrauterine device expulsion among adolescents and young women. J Pediatr Adolesc Gynecol. 2021;34:362-5.
50. Hubacher D. Copper intrauterine device use by nulliparous women: review of side effects. Contraception. 2007;75(6 suppl):S8-11.
51. Aoun J, Dines VA, Stovall DW, Mete M, Nelson CB, Gomez-Lobo V. Effects of age, parity, and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol. 2014;123:585-92.
52. Madden T, McNicholas C, Zhao Q, Secura GM, Eisenberg DL, Peipert JF. Association of age and parity with intrauterine device expulsion. Obstet Gynecol. 2014;124:718-26.
53. Eisenberg DL, Schreiber CA, Turok DK, Teal SB, Westhoff CL, Creinin MD. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system. Contraception. 2015;92:10-6.
54. Gemzell-Danielsson K, Apter D, Hauck B, Schmelter T, Rybowski S, Rosen K, et al. The effect of age, parity and body mass index on the efficacy, safety, placement and user satisfaction associated with two low-dose levonorgestrel intrauterine contraceptive systems: subgroup analyses of data from a phase iii trial. PLoS One. 2015;10:e0135309.
55. Lohr PA, Lyus R, Prager S. Use of intrauterine devices in nulliparous women. Contraception. 2017;95:529-37.
56. Faculty of Sexual and Reproductive Healthcare. FSRH Clinical Guideline: Intrauterine Contraception [Internet]. 2015. (Amended 2019 Sep) [cited 2021 Jan 27]. Available from: https://www.fsrh.org/standards-and-guidance/documents/ceuguidanceintrauterinecontraception/
57. Thonneau P, Almont T, de La Rochebrochard E, Maria B. Risk factors for IUD failure: results of a large multicentre case-control study. Hum Reprod. 2006;21:2612-6.
58. Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril. 2009; 91:1646-53.
59. Vickery Z, Madden T, Zhao Q, Secura GM, Allsworth JE, Peipert JF. Weight change at 12 months in users of three progestin-only contraceptive methods. Contraception. 2013;88:503-8.
60. Romano ME, Braun-Courville DK. Assessing weight status in adolescent and young adult users of the etonogestrel contraceptive implant. J Pediatr Adolesc Gynecol. 2019;32:409-14.
61. Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998-2007.
62. Todd N, Black A. Contraception for adolescents. J Clin Res Pediatr Endocrinol. 2020;12:28-40.
63. Bonny AE, Ziegler J, Harvey R, Debanne SM, Secic M, Cromer BA. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med. 2006;160:40-5.
64. Lopez LM, Ramesh S, Chen M, Edelman A, Otterness C, Trussell J, et al. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev. 2016;8:Cd008815.
65. Bonny AE, Secic M, Cromer B. Early weight gain related to later weight gain in adolescents on depot medroxyprogesterone acetate. Obstet Gynecol. 2011;117:793-7.
66. Steenland MW, Zapata LB, Brahmi D, Marchbanks PA, Curtis KM. Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review. Contraception. 2013;87:611-24.
67. Jirakittidul P, Somyaprasert C, Angsuwathana S. Prevalence of documented excessive weight gain among adolescent girls and young women using depot medroxyprogesterone acetate. J Clin Med Res. 2019;11:326-31.
68. Kaunitz AM. Long-acting injectable contraception with depot medroxyprogesterone acetate. Am J Obstet Gynecol. 1994;170:1543-9.
69. Gbolade BA. Depo-provera and bone density. J Fam Plann Reprod Health Care. 2002;28:7-11.
70. World Health Organization. Prevention and management of osteoporosis: report of a WHO scientific group [Internet]. 2000 [cited 2020 Sep 20]. Available from: http://apps.who.int/iris/bitstream/handle/10665/42841/WHO_TRS_921.pdf?sequence=1
71. Di Meglio G, Crowther C, Simms J. Contraceptive care for Canadian youth. Paediatr Child Health. 2018;23:271-7.
72. Bonjour J-P, Rizzoli R. Bone acquisition in adolescence. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. 2nd ed. California: Academic Press; 2001. p. 621-38.
73. Karlsson C, Obrant KJ, Karlsson M. Pregnancy and lactation confer reversible bone loss in humans. Osteoporos Int. 2001;12:828-34.
74. Sowers M, Corton G, Shapiro B, Jannausch ML, Crutchfield M, Smith ML, et al. Changes in bone density with lactation. JAMA. 1993;269:3130-5.
75. Ulrich CM, Georgiou CC, Snow-Harter CM, Gillis DE. Bone mineral density in mother-daughter pairs: relations to lifetime exercise, lifetime milk consumption, and calcium supplements. Am J Clin Nutr. 1996;63:72-9.
76. Berenson AB, Radecki CM, Grady JJ, Rickert VI, Thomas A. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol. 2001;98:576-82.
77. Clark MK, Sowers M, Levy B, Nichols S. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate. Fertil Steril. 2006;86: 1466-74.
78. Clark MK, Sowers MR, Nichols S, Levy B. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Fertil Steril. 2004;82:1580-6.
79. Kaunitz AM, Miller PD, Rice VM, Ross D, McClung MR. Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation. Contraception. 2006;74:90-9.
80. Baeten JM, Nyange PM, Richardson BA, Lavreys L, Chohan B, Martin HL, Jr, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol. 2001;185:380-5.
81. Cromer BA, Bonny AE, Stager M, Lazebnik R, Rome E, Ziegler J, et al. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study. Fertil Steril. 2008;90:2060-7.
82. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology. 2002;13:581-7.
83. Cundy T, Cornish J, Evans MC, Roberts H, Reid IR. Recovery of bone density in women who stop using medroxyprogesterone acetate. BMJ. 1994;308:247-8.
84. Harel Z, Johnson CC, Gold MA, Cromer B, Peterson E, Burkman R, et al. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Contraception. 2010; 81:281-91.
85. Johnson CC, Burkman RT, Gold MA, Brown RT, Harel Z, Bruner A, et al. Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density. Contraception. 2008;77:239-48.
86. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med. 2005;159:139-44.
87. Kaunitz AM, Arias R, McClung M. Bone density recovery after depot medroxyprogesterone acetate injectable contraception use. Contraception. 2008;77:67-76.
88. The American College of Obstetricians and Gynecologists. Committee Opinion No. 602: Depot medroxyprogesterone acetate and bone effects. Obstet Gynecol. 2014;123:1398-402.
89. Kyvernitakis I, Kostev K, Nassour T, Thomasius F, Hadji P. The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK. Osteoporos Int. 2017; 28:291-7.
90. Raine-Bennett T, Chandra M, Armstrong MA, Alexeeff S, Lo JC. Depot medroxyprogesterone acetate, oral contraceptive, intrauterine device use, and fracture risk. Obstet Gynecol. 2019; 134:581-9.
91. Golden NH. Bones and birth control in adolescent girls. J Pediatr Adolesc Gynecol. 2020;33: 249-54.
92. Powell A. Choosing the right oral contraceptive pill for teens. Pediatr Clin North Am. 2017; 64:343-58.
93. Raine TR, Foster-Rosales A, Upadhyay UD, Boyer CB, Brown BA, Sokoloff A, et al. One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives. Obstet Gynecol. 2011;117:363-71.
94. Panyavaranant P, Santibenchakul S, Jaisamrarn U. Compliance of different contraceptive methods in thai Women. Thai Journal of Obstetrics and Gynaecology. 2015;23:130-8.
95. Practice Bulletin No. 110: Noncontraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010;115:206-18.
96. Ziglar S, Hunter TS. The effect of hormonal oral contraception on acquisition of peak bone mineral density of adolescents and young women. J Pharm Pract. 2012;25:331-40.
97. Goshtasebi A, Brajic TS, Scholes D, Goldberg TBL, Berenson A, Prior JC. Adolescent use of combined hormonal contraception and peak bone mineral density accrual: a meta-analysis of international prospective controlled studies. Clin Endocrinol (Oxf). 2019;90:517-24.
98. Gersten J, Hsieh J, Weiss H, Ricciotti NA. Effect of extended 30 µg ethinyl estradiol with continuous low-dose ethinyl estradiol and cyclic 20 µg ethinyl estradiol oral contraception on adolescent bone density: a randomized trial. J Pediatr Adolesc Gynecol. 2016;29:635-42.
99. Agostino H, Di Meglio G. Low-dose oral contraceptives in adolescents: how low can you go? J Pediatr Adolesc Gynecol. 2010;23:195-201.
100. Scholes D, Hubbard RA, Ichikawa LE, LaCroix AZ, Spangler L, Beasley JM, et al. Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation. J Clin Endocrinol Metab. 2011;96:E1380-7.
101. Bitzer J, Abalos V, Apter D, Martin R, Black A. Targeting factors for change: contraceptive counselling and care of female adolescents. Eur J Contracept Reprod Health Care. 2016;21:417-30.
102. Eisenberg DL, Allsworth JE, Zhao Q, Peipert JF. Correlates of dual-method contraceptive use: an analysis of the National Survey of Family Growth (2006-2008). Infect Dis Obstet Gynecol. 2012;2012:717163.
103. Potter J, Santelli JS. Adolescent contraception: review and guidance for pediatric clinicians. Minerva Pediatr. 2015;67:33-45.
104. Stancil SL, Miller M, Briggs H, Lynch D, Goggin K, Kearns G. Contraceptive provision to adolescent females prescribed teratogenic medications. Pediatrics. 2016;137.
105. Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al. Preconceptional counseling. In: Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, Casey BM, Sheffield JS, editors. Williams Obstetrics. 24th ed. New York: McGraw-Hill Education; 2014. p. 156-66.
106. Trussell J, Hedley A, Raymond E. Ectopic pregnancy following use of progestin-only ECPs. J Fam Plann Reprod Health Care. 2003;29:249.
107. Pongchaiyakul C, Rojroongwasinkul N, Chotmongkol R, Kosulwat V, Charoenkiatkul S, Rajatanavin R. Bone mineral density in rural Thai adults living in Khon Kaen province. J Med Assoc Thai. 2002;85:235-44.